282 related articles for article (PubMed ID: 17656824)
21. CD36 mediates the innate host response to beta-amyloid.
El Khoury JB; Moore KJ; Means TK; Leung J; Terada K; Toft M; Freeman MW; Luster AD
J Exp Med; 2003 Jun; 197(12):1657-66. PubMed ID: 12796468
[TBL] [Abstract][Full Text] [Related]
22. Innate immunity in Alzheimer's disease: a complex affair.
Guillot-Sestier MV; Town T
CNS Neurol Disord Drug Targets; 2013 Aug; 12(5):593-607. PubMed ID: 23574177
[TBL] [Abstract][Full Text] [Related]
23. The LPS receptor (CD14) links innate immunity with Alzheimer's disease.
Fassbender K; Walter S; Kühl S; Landmann R; Ishii K; Bertsch T; Stalder AK; Muehlhauser F; Liu Y; Ulmer AJ; Rivest S; Lentschat A; Gulbins E; Jucker M; Staufenbiel M; Brechtel K; Walter J; Multhaup G; Penke B; Adachi Y; Hartmann T; Beyreuther K
FASEB J; 2004 Jan; 18(1):203-5. PubMed ID: 14597556
[TBL] [Abstract][Full Text] [Related]
24. Effects of CX3CR1 and Fractalkine Chemokines in Amyloid Beta Clearance and p-Tau Accumulation in Alzheimer's Disease (AD) Rodent Models: Is Fractalkine a Systemic Biomarker for AD?
Merino JJ; Muñetón-Gómez V; Alvárez MI; Toledano-Díaz A
Curr Alzheimer Res; 2016; 13(4):403-12. PubMed ID: 26567742
[TBL] [Abstract][Full Text] [Related]
25. Gene expression changes by amyloid beta peptide-stimulated human postmortem brain microglia identify activation of multiple inflammatory processes.
Walker DG; Link J; Lue LF; Dalsing-Hernandez JE; Boyes BE
J Leukoc Biol; 2006 Mar; 79(3):596-610. PubMed ID: 16365156
[TBL] [Abstract][Full Text] [Related]
26. Role of the peripheral innate immune system in the development of Alzheimer's disease.
Le Page A; Dupuis G; Frost EH; Larbi A; Pawelec G; Witkowski JM; Fulop T
Exp Gerontol; 2018 Jul; 107():59-66. PubMed ID: 29275160
[TBL] [Abstract][Full Text] [Related]
27. Antibody-mediated phagocytosis of the amyloid beta-peptide in microglia is differentially modulated by C1q.
Webster SD; Galvan MD; Ferran E; Garzon-Rodriguez W; Glabe CG; Tenner AJ
J Immunol; 2001 Jun; 166(12):7496-503. PubMed ID: 11390503
[TBL] [Abstract][Full Text] [Related]
28. Alzheimer's disease: Innate immunity gone awry?
VanItallie TB
Metabolism; 2017 Apr; 69S():S41-S49. PubMed ID: 28129888
[TBL] [Abstract][Full Text] [Related]
29. Genomic and nongenomic signaling induced by 1α,25(OH)2-vitamin D3 promotes the recovery of amyloid-β phagocytosis by Alzheimer's disease macrophages.
Mizwicki MT; Menegaz D; Zhang J; Barrientos-Durán A; Tse S; Cashman JR; Griffin PR; Fiala M
J Alzheimers Dis; 2012; 29(1):51-62. PubMed ID: 22207005
[TBL] [Abstract][Full Text] [Related]
30. Neuroprotective properties of the innate immune system and bone marrow stem cells in Alzheimer's disease.
Simard AR; Rivest S
Mol Psychiatry; 2006 Apr; 11(4):327-35. PubMed ID: 16491130
[TBL] [Abstract][Full Text] [Related]
31. Innate immunity and transcription of MGAT-III and Toll-like receptors in Alzheimer's disease patients are improved by bisdemethoxycurcumin.
Fiala M; Liu PT; Espinosa-Jeffrey A; Rosenthal MJ; Bernard G; Ringman JM; Sayre J; Zhang L; Zaghi J; Dejbakhsh S; Chiang B; Hui J; Mahanian M; Baghaee A; Hong P; Cashman J
Proc Natl Acad Sci U S A; 2007 Jul; 104(31):12849-54. PubMed ID: 17652175
[TBL] [Abstract][Full Text] [Related]
32. Involvement of IL-10R/STAT3 pathway in amyloid β clearance by microlgia in Alzheimer's disease.
Liu H; Zhou YC; Song W
Int Immunopharmacol; 2021 Dec; 101(Pt A):108263. PubMed ID: 34710847
[TBL] [Abstract][Full Text] [Related]
33. Combined treatment of amyloid-β₁₋₄₂-stimulated bone marrow-derived dendritic cells plus splenocytes from young mice prevents the development of Alzheimer's disease in APPswe/PSENldE9 mice.
Wang F; Liu H; Shen X; Ao H; Moore N; Gao L; Chen L; Hu H; Ma H; Yang Z; Zhai C; Qin J; Zhou G; Peng Y; Feng X; Li R; Liang C
Neurobiol Aging; 2015 Jan; 36(1):111-22. PubMed ID: 25085784
[TBL] [Abstract][Full Text] [Related]
34. Heme and hemoglobin suppress amyloid β-mediated inflammatory activation of mouse astrocytes.
Sankar SB; Donegan RK; Shah KJ; Reddi AR; Wood LB
J Biol Chem; 2018 Jul; 293(29):11358-11373. PubMed ID: 29871926
[TBL] [Abstract][Full Text] [Related]
35. CD40 signaling regulates innate and adaptive activation of microglia in response to amyloid beta-peptide.
Townsend KP; Town T; Mori T; Lue LF; Shytle D; Sanberg PR; Morgan D; Fernandez F; Flavell RA; Tan J
Eur J Immunol; 2005 Mar; 35(3):901-10. PubMed ID: 15688347
[TBL] [Abstract][Full Text] [Related]
36. Complex regulation of acute and chronic neuroinflammatory responses in mouse models deficient for nuclear factor kappa B p50 subunit.
Rolova T; Puli L; Magga J; Dhungana H; Kanninen K; Wojciehowski S; Salminen A; Tanila H; Koistinaho J; Malm T
Neurobiol Dis; 2014 Apr; 64():16-29. PubMed ID: 24345324
[TBL] [Abstract][Full Text] [Related]
37. Emerging Roles of Cells and Molecules of Innate Immunity in Alzheimer's Disease.
Tamburini B; Badami GD; La Manna MP; Shekarkar Azgomi M; Caccamo N; Dieli F
Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569296
[TBL] [Abstract][Full Text] [Related]
38. The neuroinflammatory response in plaques and amyloid angiopathy in Alzheimer's disease: therapeutic implications.
Rozemuller AJ; van Gool WA; Eikelenboom P
Curr Drug Targets CNS Neurol Disord; 2005 Jun; 4(3):223-33. PubMed ID: 15975026
[TBL] [Abstract][Full Text] [Related]
39. Methods to monitor monocytes-mediated amyloid-beta uptake and phagocytosis in the context of adjuvanted immunotherapies.
Hallé M; Tribout-Jover P; Lanteigne AM; Boulais J; St-Jean JR; Jodoin R; Girouard MP; Constantin F; Migneault A; Renaud F; Didierlaurent AM; Mallett CP; Burkhart D; Pilorget A; Palmantier R; Larocque D
J Immunol Methods; 2015 Sep; 424():64-79. PubMed ID: 26002154
[TBL] [Abstract][Full Text] [Related]
40. Genomics of Alzheimer's disease implicates the innate and adaptive immune systems.
Li Y; Laws SM; Miles LA; Wiley JS; Huang X; Masters CL; Gu BJ
Cell Mol Life Sci; 2021 Dec; 78(23):7397-7426. PubMed ID: 34708251
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
